HIV Proteins and Endothelial Dysfunction: Implications in Cardiovascular Disease.

Area of Science:

• Cardiovascular Disease Research
• Infectious Disease Immunology
• Molecular Virology

Background:

• Antiretroviral therapy (ART) has improved life expectancy for HIV-infected individuals.
• HIV-infected individuals face increased risks of non-AIDS-related complications, particularly cardiovascular disease (CVD).
• HIV infection contributes to CVD independently of traditional risk factors, with endothelial dysfunction as a key mechanism.

Purpose of the Study:

• To review the interactions between HIV proteins and endothelial cells.
• To summarize the implications of these interactions for cardiovascular disease.
• To analyze in vitro and in vivo studies on HIV protein-induced endothelial dysfunction.

Main Methods:

• Review of current scientific literature on HIV-endothelial cell interactions.
• Analysis of in vitro and in vivo studies examining endothelial dysfunction in response to HIV proteins.
• Discussion of molecular mechanisms underlying viral protein-induced vascular damage.

Main Results:

• HIV proteins (gp120, Tat, Nef) are secreted or transferred to endothelial cells.
• These proteins induce endothelial dysfunction, including increased adhesiveness, permeability, proliferation, apoptosis, oxidative stress, and cytokine secretion.
• HIV-induced endothelial dysfunction is a critical link to atherosclerosis and CVD in infected individuals.

Conclusions:

• HIV infection directly impairs endothelial cell function through viral proteins.
• Understanding these molecular mechanisms is crucial for preventing and treating CVD in HIV patients.
• Targeting HIV protein interactions with the endothelium may offer novel therapeutic strategies.